In their article, Prosser and colleagues evaluate the cost-effectiveness of recombinant zoster vaccine compared with zoster vaccine live and no zoster vaccination. The editorial discusses the findings in light of current immunization recommendations.
from A via a.sfakia on Inoreader http://bit.ly/2Nkjy0x
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,